CompletedNot Applicable

Study on the Reduction of Catheter-related Infections by Use of Self-disinfecting Venous and Arterial Access Caps

Germany598 participantsStarted 2017-11-01

Plain-language summary

Observational study on the reduction of catheter-related Infections by use of self-disinfecting venous and arterial access caps (Curos caps ;3M, Saint Paul, MN, USA)

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * every patient in the hemato-oncological department who received at least one CVC was included in the study Exclusion Criteria: * none

What they're measuring

Number of CLABSI

Timeframe: 12 Months

Trial details

NCT IDNCT04534348

SponsorUniversity of Cologne

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-12-31

View on ClinicalTrials.gov More CLABSI - Central Line Associated Bloodstream Infection trials